Zevra Therapeutics (ZVRA) Current Assets (2016 - 2025)
Historic Current Assets for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $225.1 million.
- Zevra Therapeutics' Current Assets rose 12637.82% to $225.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.1 million, marking a year-over-year increase of 12637.82%. This contributed to the annual value of $86.0 million for FY2024, which is 104.79% down from last year.
- Zevra Therapeutics' Current Assets amounted to $225.1 million in Q3 2025, which was up 12637.82% from $226.3 million recorded in Q2 2025.
- Over the past 5 years, Zevra Therapeutics' Current Assets peaked at $226.3 million during Q2 2025, and registered a low of $60.9 million during Q2 2024.
- Its 5-year average for Current Assets is $111.5 million, with a median of $99.4 million in 2024.
- Per our database at Business Quant, Zevra Therapeutics' Current Assets skyrocketed by 155311.89% in 2021 and then plummeted by 4112.66% in 2024.
- Quarter analysis of 5 years shows Zevra Therapeutics' Current Assets stood at $115.1 million in 2021, then fell by 19.31% to $92.8 million in 2022, then decreased by 6.35% to $86.9 million in 2023, then fell by 1.05% to $86.0 million in 2024, then surged by 161.68% to $225.1 million in 2025.
- Its Current Assets was $225.1 million in Q3 2025, compared to $226.3 million in Q2 2025 and $81.6 million in Q1 2025.